Jeffrey A. Leerink is the Chief Executive Officer of SVB Leerink. Mr. Leerink is charged with defining, leading and executing the firm’s overarching business strategy and driving clarity, alignment and profitability across the entire business. Under Mr. Leerink’s leadership, the firm has grown to become a leading healthcare investment bank and company building partner.
Mr. Leerink founded Leerink Partners in 1995 and in 2019 merged the firm with SVB Financial Group, parent company to Silicon Valley Bank, to become SVB’s investment banking platform. The firm is focused on providing differentiated healthcare knowledge and equity capital markets, equity research and mergers and acquisitions expertise to help its clients define and achieve their strategic and capital markets objectives.
In 2008, Mr. Leerink co-founded and was a member of the Board of Directors of Humedica, Inc., a clinical intelligence company that was incubated at Leerink Partners. In 2013 the company was acquired by Optum, a subsidiary of UnitedHealth Group.
Mr. Leerink currently serves on the Board of Fog Pharmaceuticals. Additionally, he is a Board Director and the former Chairman of the Board at Big Brothers Big Sisters of Massachusetts Bay. Mr. Leerink is a member of the Harvard Medical School Board of Fellows and is the Vice Chair of the New England Chapter of CEO’s Against Cancer.
Mr. Leerink holds a B.A. in Economics from Union College.